Eculizumab in pregnancy: a narrative overview.

Journal of Nephrology
Laura SarnoDomenico Russo

Abstract

Pregnancy can be a dangerous trigger for patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), or hemolysis, elevated liver enzymes and low platelet (HELLP) syndrome. Due to the possibility of several serious complications, pregnancy is somewhat discouraged in the presence of the above diseases. Eculizumab is a humanized antibody that may dramatically change the clinical course of PNH, aHUS and HELLP syndrome. However, data on the safety of eculizumab in pregnancy are scarce. In this narrative overview, we summarize current evidence on the use of eculizumab during pregnancy in women with PNH, aHUS and HELLP syndrome. Eculizumab is not present in breast milk, and the levels observed in umbilical cord blood samples are not sufficient to affect the concentrations of complement in newborns. Therefore, eculizumab may be regarded as safe in pregnancy. Nonetheless, given that data on eculizumab in pregnancy are limited, it is not possible to completely exclude risks for both mother and fetus in treating PNH, aHUS and HELLP syndrome.

References

Aug 1, 1997·Journal of Biochemistry·T KinoshitaJ Takeda
Sep 15, 2000·Pediatrics International : Official Journal of the Japan Pediatric Society·S HashiraK Yoshino
Aug 22, 2006·Obstetrical & Gynecological Survey·Stefania FieniRoberto Delsignore
Oct 28, 2008·Leukemia Research·Alexey V DanilovKenneth B Miller
Jan 16, 2009·Lancet·Charles Parker
Feb 16, 2010·British Journal of Haematology·Richard KellyPeter Hillmen
Jun 18, 2010·British Journal of Haematology·Roberto MarascaLucio Luzzatto
Jan 12, 2012·Clinical & Developmental Immunology·Patricia PalmeiraMagda Carneiro-Sampaio
Aug 11, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Fadi FakhouriVéronique Frémeaux-Bacchi
Dec 12, 2012·Placenta·R M Burwick, B B Feinberg
Jul 26, 2013·Obstetrics and Gynecology·Gianluigi ArdissinoMassimo Cugno
Dec 4, 2014·Immunobiology·Randi Fykse HallstensenTom Eirik Mollnes
Feb 18, 2015·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Gianluca GessoniAlberto Tregnaghi
Feb 18, 2015·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Marie-Christiane VekemansLucienne Michaux
Sep 10, 2015·The New England Journal of Medicine·Richard J KellyRegis Peffault de Latour
Sep 3, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Aude ServaisYahsou Delmas
Jan 20, 2017·Experimental Hematology & Oncology·Gabriela AndriesSavneek Chugh
Jan 20, 2017·Case Reports in Nephrology and Dialysis·Erol DemirAydin Turkmen
Dec 29, 2017·Journal of the American Society of Nephrology : JASN·Martina GagglAlice Schmidt

❮ Previous
Next ❯

Citations

Apr 30, 2020·American Journal of Reproductive Immunology : AJRI·Asmaa BeltagyCecilia B Chighizola
Aug 11, 2020·Immunotherapy·Katrin Giglhuber, Achim Berthele
Sep 16, 2020·Muscle & Nerve·Kavita M Grover, Naganand Sripathi
Sep 15, 2020·Therapeutic Advances in Neurological Disorders·Ayse AltintasKerstin Hellwig
Apr 21, 2020·The Journal of Clinical Investigation·Eleni Gavriilaki, Robert A Brodsky
Jan 20, 2019·BMJ Case Reports·Dileep KumarAnjali Acharya
Feb 23, 2020·Nature Reviews. Neurology·Yang Mao-DraayerKerstin Hellwig
Apr 29, 2020·British Journal of Haematology·Ann Kinga Malinowski
Oct 5, 2020·Journal of Neurology·Trygve HolmøyØivind Torkildsen
Sep 29, 2020·British Journal of Clinical Pharmacology·Gaby A M EliesenFrans G M Russel
Nov 24, 2019·Blood Reviews·Allyson M PishkoDouglas B Cines
Feb 5, 2021·Biomedicines·Ilaria MormileFrancesca Wanda Rossi
Jun 20, 2020·Advances in Chronic Kidney Disease·Kana Amari ChinchillaBelinda Jim
Apr 6, 2021·Current Treatment Options in Neurology·Madina TugizovaMay Htwe Han
May 26, 2021·Revista española de anestesiología y reanimación·E Simón PoloJ A Monsalve Naharro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.